Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / January / Parkinson's Aggravated by Nanoplastics Exposure
Omics Clinical Omics Metabolomics & Lipidomics

Parkinson's Aggravated by Nanoplastics Exposure

Mouse study suggests environmental nanoplastics may exacerbate Parkinson's disease through metabolic dysregulation in the gut, brain, and liver

By Kathryn Wighton 01/27/2026 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Share

Clinical Report: Parkinson's Aggravated by Nanoplastics Exposure

Overview

Chronic exposure to polystyrene nanoplastics in an A53T α-synuclein mouse model resulted in significant gastrointestinal and neurological changes, including increased cell death in the gut lining and altered gut microbiota. Notably, the study identified elevated levels of α-synuclein and inflammatory markers in the brain tissue of exposed mice.

Background

The growing prevalence of plastic pollution poses significant health risks, particularly through the exposure to micro- and nanoplastics. These particles are increasingly found in human tissues and may contribute to various health issues, including neurodegenerative diseases like Parkinson's. Understanding the effects of nanoplastics on neurological health is crucial for developing preventive strategies and therapeutic interventions.

Data Highlights

OutcomeFindings
Mucus-producing cellsFewer in nanoplastic-exposed mice
Cell death in gut liningIncreased in exposed mice
Gut microbiotaDiverse microbial composition with more Desulfovibrio
Metabolomic changesOver 200 metabolites significantly altered
Inflammation markersElevated interleukin-6 and lipopolysaccharide levels in brain

Key Findings

  • Chronic exposure to polystyrene nanoplastics led to increased cell death in the gut lining.
  • Altered gut microbiota composition included a higher presence of Desulfovibrio, linked to hydrogen sulfide production.
  • Significant changes in over 200 metabolites related to amino acid and fat processing were observed.
  • Brain tissue showed elevated levels of α-synuclein and inflammatory markers after nanoplastic exposure.
  • Histopathological evaluation revealed signs of liver inflammation in exposed mice.

Clinical Implications

These findings suggest that exposure to nanoplastics may exacerbate gastrointestinal and neurological conditions, particularly in individuals predisposed to Parkinson's disease. Clinicians should consider environmental exposures in the management of neurodegenerative diseases and advocate for further research into the health impacts of plastic pollution.

Conclusion

The study highlights the potential neurotoxic effects of nanoplastics, emphasizing the need for further investigation into their role in exacerbating neurodegenerative diseases like Parkinson's. Addressing plastic pollution is critical for public health and disease prevention.

References

  1. Rafey and Siddiqui, Archives of Toxicology, 2023 -- Plastic pollution and health
  2. Patil et al., Archives of Toxicology, 2022 -- Neurotoxic risks of micro- and nanoplastics
  3. Bai et al., Archives of Toxicology, 2022 -- Microplastics and cardiovascular disease
  4. International Parkinson and Movement Disorder Society, PMC, 2026 -- Update on Treatments for Parkinson's Disease
  5. npj Parkinson's Disease, 2026 -- Micro-nanoplastics and Parkinson’s disease
  6. The ASCO Post — Microplastics Found in 90% of Prostate Cancer Samples
  7. Update on Treatments for Parkinson's Disease Motor Fluctuations – An International Parkinson and Movement Disorder Society Evidence‐Based Medicine Review - PMC
  8. UNITED STATES
  9. Micro-nanoplastics and Parkinson’s disease: evidence and perspectives | npj Parkinson's Disease

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Kathryn Wighton

Editor, Conexiant

More Articles by Kathryn Wighton

False

Advertisement

Recommended

False

Related Content

The Analytical Scientist Innovation Awards 2024: #7
Omics
The Analytical Scientist Innovation Awards 2024: #7

December 2, 2024

4 min read

Frank Steemers, co-founder and CSO of Scale Biosciences, tells us the story of ScalePlex – the 7th ranked innovation on this year’s Awards

The Analytical Scientist Innovation Awards 2024: #4
Omics
The Analytical Scientist Innovation Awards 2024: #4

December 5, 2024

6 min read

Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards

Let Me See That Brain
Omics
Let Me See That Brain

December 9, 2024

1 min read

TRISCO sets a new standard for 3D RNA imaging, delivering high-resolution and uniform images to offer insights into brain function and anatomy

The Analytical Scientist Innovation Awards 2024
Omics
The Analytical Scientist Innovation Awards 2024

December 11, 2024

10 min read

Meet the products – and the experts – defining analytical innovation in 2024

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.